Advanced search
Publication Cover
Expert Review of Precision Medicine and Drug Development
Personalized medicine in drug development and clinical practice
Volume 5, 2020 - Issue 3
Submit an article Journal homepage
223
Views
15
CrossRef citations to date
0
Altmetric
Review

Pharmacogenomics of drugs used to treat brain disorders

Ramon CacabelosInternational Center of Neuroscience and Genomic Medicine, EuroEspes Biomedical Research Center, Corunna, SpainCorrespondence[email protected]
View further author information
Pages 181-234 | Received 21 Nov 2019, Accepted 02 Mar 2020, Published online: 17 Mar 2020

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ramón Cacabelos. (2022) What have we learnt from past failures in Alzheimer’s disease drug discovery?. Expert Opinion on Drug Discovery 17:4, pages 309-323.
Read now
Ramón Cacabelos. (2020) Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease. Expert Opinion on Drug Metabolism & Toxicology 16:8, pages 673-701.
Read now

Articles from other publishers (13)

Barbara Vuic, Tina Milos, Lucija Tudor, Matea Nikolac Perkovic, Marcela Konjevod, Gordana Nedic Erjavec, Vladimir Farkas, Suzana Uzun, Ninoslav Mimica & Dubravka Svob Strac. (2023) Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms. Genes 14:11, pages 2048.
Crossref
Olaia Martínez-Iglesias, Vinogran Naidoo, Iván Carrera, Juan Carlos Carril, Natalia Cacabelos & Ramón Cacabelos. (2023) Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders. Biology 12:9, pages 1156.
Crossref
Ramón Cacabelos, Juan C Carril, Lola Corzo, Rocío Pego, Natalia Cacabelos, Margarita Alcaraz, Adriana Muñiz, Olaia Martínez-Iglesias & Vinogran Naidoo. (2023) Pharmacogenetics of anxiety and depression in Alzheimer's disease. Pharmacogenomics 24:1, pages 27-57.
Crossref
Susan Miller, Walter Moos, Barbara Munk, Stephen Munk, Charles Hart & David Spellmeyer. 2023. Managing the Drug Discovery Process. Managing the Drug Discovery Process 207 338 .
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, Lola Corzo, Natalia Cacabelos, Rocío Pego & Juan C. Carril. (2022) Personalized Management and Treatment of Alzheimer’s Disease. Life 12:3, pages 460.
Crossref
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, Lola Corzo, Natalia Cacabelos, Rocío Pego & Juan C. Carril. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development 275 387 .
Ramón Cacabelos, Vinogran Naidoo, Lola Corzo, Natalia Cacabelos & Juan C. Carril. (2021) Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions. International Journal of Molecular Sciences 22:24, pages 13302.
Crossref
Antonio F. Pardiñas, Michael J. Owen & James T.R. Walters. (2021) Pharmacogenomics: A road ahead for precision medicine in psychiatry. Neuron 109:24, pages 3914-3929.
Crossref
Ramón Cacabelos, Iván Carrera, Olaia Martínez, Ramón Alejo, Lucía Fernández‐Novoa, Pablo Cacabelos, Lola Corzo, Susana Rodríguez, Margarita Alcaraz, Laura Nebril, Iván Tellado, Natalia Cacabelos, Rocío Pego, Vinogran Naidoo & Juan C. Carril. (2021) Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics. Medicinal Research Reviews 41:5, pages 2841-2886.
Crossref
Ramón Cacabelos, Iván Carrera, Olaia Martínez, Vinogran Naidoo, Natalia Cacabelos, Gjumrakch Aliev & Juan C. Carril. (2021) Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson's disease. Drug Development Research 82:5, pages 695-706.
Crossref
Ramón Cacabelos, Juan Carril, Lola Corzo, Lucía Fernández-Novoa, Rocío Pego, Natalia Cacabelos, Pablo Cacabelos, Margarita Alcaraz, Iván Tellado & Vinogran Naidoo. (2021) Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease. Pharmaceuticals 14:4, pages 366.
Crossref
Regi T. Alexander, Peter E. Langdon, Jean O'Hara, Andreana Howell, Tadhgh Lane, Reena Tharian & Rohit Shankar. (2020) Psychiatry and neurodevelopmental disorders: experts by experience, clinical care and research. The British Journal of Psychiatry 218:1, pages 1-3.
Crossref
Ramon Cacabelos. (2020) Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia. International Journal of Molecular Sciences 21:9, pages 3059.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.